PMC:7228307 / 1976-2469
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 31 | 396-400 | Gene | denotes | FcγR | Gene:2213 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T10 | 43-57 | Body_part | denotes | immunoglobulin | http://purl.org/sig/ont/fma/fma62871 |
| T11 | 58-63 | Body_part | denotes | (Ig)G | http://purl.org/sig/ont/fma/fma62872 |
| T12 | 59-61 | Body_part | denotes | Ig | http://purl.org/sig/ont/fma/fma62871 |
| T13 | 471-479 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T26 | 25-27 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
| T27 | 64-72 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activate |
| T28 | 86-87 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T29 | 371-381 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activating |
| T30 | 396-398 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T7 | 138-146 | Chemical | denotes | effector | http://purl.obolibrary.org/obo/CHEBI_35224 |
| T8 | 401-409 | Chemical | denotes | effector | http://purl.obolibrary.org/obo/CHEBI_35224 |
LitCovid-sample-MedDRA
| Id | Subject | Object | Predicate | Lexical cue | meddra_id |
|---|---|---|---|---|---|
| T3 | 43-57 | http://purl.bioontology.org/ontology/MEDDRA/10022891 | denotes | immunoglobulin | http://purl.bioontology.org/ontology/MEDDRA/10021496 |
| T4 | 59-61 | http://purl.bioontology.org/ontology/MEDDRA/10022891 | denotes | Ig | http://purl.bioontology.org/ontology/MEDDRA/10021496 |
LitCovid-sample-PD-IDO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T9 | 122-126 | http://purl.obolibrary.org/obo/IDO_0000531 | denotes | host |
| T10 | 147-156 | http://purl.obolibrary.org/obo/BFO_0000034 | denotes | functions |
| T11 | 200-216 | http://purl.obolibrary.org/obo/GO_0006955 | denotes | immune responses |
| T12 | 410-419 | http://purl.obolibrary.org/obo/BFO_0000034 | denotes | functions |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
|---|---|---|---|---|---|
| 31 | 396-400 | Gene | denotes | FcγR | Gene:2213 |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T14 | 0-217 | Sentence | denotes | Fragment crystallizable (Fc) receptors for immunoglobulin (Ig)G activate and modulate a powerful network of inflammatory, host‐protective effector functions that are central to effective and balanced immune responses. |
| T15 | 218-301 | Sentence | denotes | These responses are also harnessed—or avoided—by therapeutic monoclonal antibodies. |
| T16 | 302-493 | Sentence | denotes | The use and manipulation of IgG2, IgG4 as well as IgG1 for optimized activating or inhibitory FcγR effector functions will underpin the development of potent "next‐gen" antibody therapeutics. |
LitCovid-sample-PD-FMA
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T10 | 43-57 | Body_part | denotes | immunoglobulin | http://purl.org/sig/ont/fma/fma62871 |
| T11 | 58-63 | Body_part | denotes | (Ig)G | http://purl.org/sig/ont/fma/fma62872 |
| T12 | 59-61 | Body_part | denotes | Ig | http://purl.org/sig/ont/fma/fma62871 |
| T13 | 471-479 | Body_part | denotes | antibody | http://purl.org/sig/ont/fma/fma62871 |
LitCovid-sample-PD-GO-BP-0
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2 | 200-216 | http://purl.obolibrary.org/obo/GO_0006955 | denotes | immune responses |
LitCovid-sample-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2 | 200-216 | http://purl.obolibrary.org/obo/GO_0006955 | denotes | immune responses |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T2 | 200-216 | http://purl.obolibrary.org/obo/GO_0006955 | denotes | immune responses |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T14 | 0-217 | Sentence | denotes | Fragment crystallizable (Fc) receptors for immunoglobulin (Ig)G activate and modulate a powerful network of inflammatory, host‐protective effector functions that are central to effective and balanced immune responses. |
| T15 | 218-301 | Sentence | denotes | These responses are also harnessed—or avoided—by therapeutic monoclonal antibodies. |
| T16 | 302-493 | Sentence | denotes | The use and manipulation of IgG2, IgG4 as well as IgG1 for optimized activating or inhibitory FcγR effector functions will underpin the development of potent "next‐gen" antibody therapeutics. |